MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+59.95%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$121M
AUM Growth
+$121M
(+38%)
Cap. Flow
-$371K
Cap. Flow
% of AUM
-0.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$1.66M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2M |
| 2 |
NEXI
NexImmune, Inc. Common Stock
NEXI
|
$28K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $37.2M | 30.85% | 7,373,413 +328,913 | +5% | +$1.66M |
|
2
Invivyd
IVVD
$204M
| $36.4M | 30.19% | 9,248,250 | – | – |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $15.7M | 12.99% | 523,280 | – | – |
|
|
SLN
4
Silence Therapeutics
SLN
$227M
| $6.32M | 5.24% | 363,800 | – | – |
|
5
Curis
CRIS
$20.9M
| $5.38M | 4.46% | 421,951 | – | – |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $5.21M | 4.32% | 142,800 -54,900 | -28% | -$2M |
|
7
BridgeBio Pharma
BBIO
$9.89B
| $4.89M | 4.05% | 121,200 | – | – |
|
8
ProQR Therapeutics
PRQR
$237M
| $3.78M | 3.13% | 1,910,600 | – | – |
|
9
TG Therapeutics
TGTX
$4.65B
| $3.7M | 3.06% | 216,600 | – | – |
|
10
Arrowhead Research
ARWR
$3.05B
| $2.06M | 1.71% | 67,400 | – | – |
|
|
NEXI
11
DELISTED
NexImmune, Inc. Common Stock
NEXI
| – | – | -133,442 | Closed | -$28K |
|